Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
(NASDAQ: KNSA) Delayed: 51.89 +0.31 (0.60%)
Previous Close $51.58    52 Week High $ 
Open $51.66    52 Week Low $ 
Day High $52.48    P/E N/A 
Day Low $51.36    EPS $ 
Volume 362,761